anim
phyla
record
found
ocean
onychophora
present
land
set
foundat
activ
research
program
sourc
marin
compound
wide
rang
speci
includ
alga
spong
coelenter
ascidian
bryozoan
bioprospect
effort
last
year
yield
compound
marin
origin
pharmacognosi
gain
understand
import
marin
natur
product
chemistri
drug
develop
g
abl
map
process
involv
drug
develop
marin
natur
product
g
gain
appreci
rang
biolog
activ
associ
compound
isol
microand
macroorgan
g
identifi
marinederiv
drug
undergo
clinic
evalu
earth
surfac
cover
vast
expans
ocean
inhabit
divers
phyla
occur
exclus
ocean
one
phylum
onychophora
report
present
land
marin
environ
provid
array
structur
uniqu
divers
constitu
produc
equal
divers
consortium
marin
organ
live
coral
reef
benthic
commun
marin
organ
highli
variabl
speci
color
morpholog
belong
sever
phyla
includ
porifera
spong
ascidiacea
sea
squirt
octacorallia
soft
coral
metabolit
marin
origin
eman
varieti
part
plant
anim
thought
produc
form
chemic
commun
defens
ward
potenti
predat
fig
potenti
rang
applic
includ
anticanc
antibacteri
antivir
antiinflammatori
antimalari
antituberculosi
activ
well
pharmacolog
industri
applic
class
compound
manufactur
marin
organ
includ
alkaloid
terpenoid
shikim
peptid
polyketid
temperatur
salin
ph
dissolv
oxygen
concentr
water
therebi
provid
use
inform
facilit
environment
studi
caution
alway
exercis
collect
marin
speci
glove
worn
collect
subsequ
handl
specimen
scuba
diver
clad
wet
suit
protect
possibl
deleteri
effect
chemic
exud
water
organ
collect
person
unfortun
experi
author
hour
sever
discomfort
rash
result
collect
spong
neofibularia
nolitanger
reef
discoveri
bay
jamaica
provid
clear
evid
regard
level
respect
accord
figur
student
snorkel
collect
marin
specimen
marin
organ
whose
chemistri
yet
investig
record
made
depth
habitat
global
posit
system
coordin
latitud
longitud
color
morpholog
associ
organ
appropri
code
system
employ
distinguish
specimen
possibl
specimen
photograph
situ
well
docksid
fig
voucher
specimen
organ
usual
preserv
aqueou
ethanol
purpos
taxonom
identif
ascidian
usual
preserv
seawat
contain
menthol
crystal
longterm
storag
formalin
solut
note
recollect
organ
prove
challeng
instanc
ascidian
speci
eg
found
thrive
mangrov
summer
one
year
could
disappear
ecolog
landscap
month
later
healthi
bed
alga
may
shortliv
dynam
factor
involv
growth
exampl
occasion
nutrient
runoff
groundwat
seepag
event
could
provid
ideal
environ
growth
select
algal
speci
environment
factor
key
marin
landscap
often
provid
sourc
frustrat
specimen
collector
prior
extract
collect
organ
specimen
may
frozen
airdri
freezedri
could
retain
fresh
state
major
marin
organ
extract
fresh
frozen
remain
specimen
lyophil
dri
air
extract
instanc
dri
algal
speci
ground
powder
prior
extract
describ
sansom
cowork
isol
antiprolif
bisprenyl
quinon
alga
perithalia
capillari
extract
marin
organ
may
carri
use
rang
organ
solvent
includ
hexan
dichloromethan
aceton
ethyl
acet
well
polar
solvent
ethanol
methanol
mani
instanc
mixtur
polar
medium
polar
nonpolar
solvent
util
extract
protocol
exampl
extract
madagascar
spong
monanchora
dianchora
achiev
ch
cl
meoh
yield
two
polycycl
guanidin
alkaloid
extract
usual
exhaust
perform
sever
day
least
three
aliquot
solvent
use
solvent
remov
vacuo
rotari
evapor
solvent
partit
anoth
strategi
employ
extract
organ
involv
singl
onestep
twostep
partit
system
usual
involv
aqueou
phase
portion
solvent
immisc
phase
kupchan
modifi
kupchan
procedur
often
employ
natur
product
describ
isol
diterpen
axinella
speci
procedur
concentr
aqueou
layer
progress
adjust
afford
three
four
differ
fraction
complex
partit
procedur
also
employ
albeit
rare
simpl
partit
commonli
employ
kupchan
scheme
util
less
frequenc
chromatograph
method
separ
includ
graviti
column
chromatographi
flash
column
chromatographi
vacuum
liquid
column
chromatographi
util
silica
gel
pack
materi
silica
gel
compon
marin
extract
separ
basi
polar
compound
polar
elut
solvent
increas
compound
increas
polar
elut
column
hydrocarbon
eg
elut
alcohol
elut
compon
column
monitor
use
thin
layer
chromatographi
tlc
plate
spot
show
sequenc
elut
compound
fig
bond
revers
phase
silica
employ
instanc
constitu
marin
extract
includ
polar
metabolit
bond
phase
includ
od
c
c
cyano
diol
column
separ
constitu
may
also
effect
use
gel
permeat
chromatographi
effect
separ
constitu
basi
size
compound
regard
sephadex
commonli
util
marin
natur
product
isol
work
resin
biobead
amberlit
also
util
separ
compon
rel
high
polar
use
separ
antivir
trisulf
triterpen
glycosid
sea
cucumb
staurocucumi
liouvillei
one
exampl
marin
natur
product
isol
work
use
hplc
employ
revers
phase
stationari
phase
system
commonplac
marin
natur
product
isol
work
c
c
semiprepar
prepar
column
use
mplc
recycl
hplc
techniqu
relat
techniqu
purif
rang
metabolit
includ
alkaloid
peptid
terpenoid
tandem
system
liquid
chromatographymass
spectrometri
system
also
employ
assist
derepl
effort
unusu
ms
peak
profil
suggest
novel
compon
present
fraction
extract
evalu
fraction
unusu
constitu
may
becom
focu
research
effort
solidphas
extract
method
also
employ
separ
compound
structur
identif
compound
isol
rang
marin
sourc
facilit
use
spectroscop
techniqu
nuclear
magnet
reson
nmr
spectroscopi
infrar
ir
spectroscopi
xray
crystallograph
techniqu
also
import
aid
determin
stereochemistri
compound
identif
nanogram
quantiti
novel
compound
becom
increasingli
facil
use
cryoprob
capillari
probe
man
probe
vitro
activ
marin
metabolit
investig
divers
rang
cell
system
includ
antiinflammatori
antimicrobi
anticanc
activ
crude
extract
fraction
crude
extract
well
pure
compound
typic
evalu
biolog
activ
vitro
biolog
evalu
isol
compound
may
perform
use
cell
line
human
subject
anim
brine
shrimp
fish
sea
urchin
among
organ
employ
evalu
compound
extract
ecolog
therapeut
import
fig
summari
biolog
activ
organ
discuss
section
present
preclin
trial
essenti
compon
process
evalu
therapeut
potenti
compound
trial
often
includ
anim
model
rat
dog
monkey
major
sourc
biolog
relev
compound
found
spong
coelenter
alga
echinoderm
ascidian
mollusc
microorgan
macroinvertebr
includ
spong
ascidian
soft
coral
found
vast
major
novel
compound
obtain
marin
environ
sourc
porifera
coelenterata
cnidaria
phyla
scheme
show
repres
structur
compound
isol
macroinvertebr
macroinvertebr
includ
spong
ascidian
soft
coral
spong
porifera
sedentari
filter
feed
metazoan
util
singl
layer
flagel
cell
choanocyt
pump
water
current
bodi
unidirect
manner
speci
spong
account
much
epifaun
biomass
extract
fresh
freezedri
spong
extract
import
sourc
biolog
activ
compound
isol
exhibit
impress
array
biolog
activ
describ
one
spong
gain
place
histori
due
promis
biolog
activ
display
halichondria
okadai
produc
halichondrin
b
underw
evalu
anticanc
agent
okada
acid
also
h
okadai
exhibit
inhibitori
activ
fig
agelaspin
antitumor
glycosphingolipid
obtain
marin
spong
agela
mauritianu
demonstr
antitumor
activ
vivo
murin
melanoma
compound
also
found
stimul
immun
system
deriv
agelaspin
underw
clinic
investig
cancer
immunotherapi
recent
extract
anoth
agela
sp
nakamurai
contain
compound
agelasin
exhibit
high
antibacteri
activ
deep
water
spong
discodermia
dissoluta
produc
discodermolid
polyhydroxyl
lacton
exhibit
anticanc
activ
well
immunosuppress
activ
found
stabil
microtubul
manner
similar
drug
taxol
underw
evalu
use
tumor
resist
taxol
dysidea
arenaria
found
contain
arenastatin
show
potent
activ
kb
cell
line
ic
pgml
girollin
substitut
imidazol
isol
spong
pseudaxinyssa
cantharella
function
inhibit
termin
step
eukaryot
protein
synthesi
enter
phase
clinic
trial
withdrawn
due
advers
hypertens
effect
seen
treat
patient
mycalamid
b
protein
synthesi
inhibitor
isol
new
zealand
spong
mycal
sp
vivo
activ
coronaviru
observ
mice
treat
mycalamid
mixtur
dosag
daili
surviv
twoweek
period
pure
mycalamid
inhibit
herp
simplex
viru
polio
viru
type
concentr
mycalamid
b
found
exhibit
potent
antivir
activ
cytotox
mycalamid
baculiferin
j
l
marin
spong
iotrochota
baculifera
found
inhibit
human
immunodefici
ic
valu
jasplakinolid
first
exampl
cyclodepsipeptid
isol
spong
macrocycl
depsipeptid
jaspi
sp
exhibit
vitro
antimicrobi
activ
minimum
inhibitori
concentr
melinacidin
gencidin
antibacteri
marinospora
sp
lynamicin
ae
antibacteri
candida
albican
topic
administr
jasplakinolid
solut
effect
similar
miconazol
nitrat
achiev
vivo
discorhabdin
r
novel
pyrroloiminoquinon
isol
southern
australian
spong
negombata
sp
antarct
latruncula
sp
found
display
antibacteri
activ
gramposit
staphylococcu
aureu
micrococcu
luteu
gramneg
bacteria
serratia
marcescen
escherichia
coli
respect
antibacteri
activ
strain
bacteri
parasit
plasmodium
falciparum
reportedli
identifi
monanchora
arbuscula
activ
agent
batzellidin
alkaloid
ic
import
isol
spongia
sp
polyhydroxyl
steroid
agosterol
function
revers
multidrug
resist
caus
overexpress
two
kind
membran
glycoprotein
cancer
cell
phylum
cnidaria
genera
sinularia
briareum
proven
prolif
sourc
novel
compound
cembranoid
sinulaflexiolid
africanen
isol
sinularia
speci
fig
exampl
speci
soft
coral
includ
taiwanes
soft
coral
cespitularia
taeniata
extract
ethanol
yield
group
verticillen
diterpenoid
includ
cespitulactam
k
compound
evalu
human
epiderm
carcinoma
murin
leukemia
cell
line
cespitulactam
k
exhibit
activ
cancer
cell
line
also
show
mark
antimicrobi
activ
luteu
cryptococcu
neoforman
methanol
extract
octocor
muricea
austera
show
vitro
activ
chloroquineresist
p
falciparum
found
contain
rang
differ
class
compound
includ
tyramin
deriv
steroid
pregnan
glycosid
sesquiterpenoid
cytotox
dolabellan
diterpen
isol
formosan
soft
coral
clavularia
inflata
var
luzoniana
bioactiv
cell
line
ed
valu
observ
tunic
sea
squirt
ascidian
belong
subphylum
tunicata
urochordata
name
cellulosecontain
protect
tunic
surround
organ
tunic
attach
substratum
usual
marin
solid
surfac
mangrov
root
rock
jetti
even
algal
speci
fig
much
like
spong
soft
coral
ascidian
also
found
good
sourc
bioactiv
agent
didemnin
b
isol
tunic
trididemnum
solidum
one
bioactiv
compound
show
remark
antivir
cytotox
activ
didemnin
b
demonstr
activ
murin
leukemia
cell
line
advanc
preclin
clinic
trial
withdrawn
due
harsh
toxic
aplidin
formal
known
dehydrodidemnin
isol
mediterranean
tunic
aplidium
albican
one
bioactiv
compound
structur
relat
didemnin
b
aplidin
found
activ
less
toxic
didemnin
b
enter
phase
clinic
trial
investig
treatment
solid
tumor
nonhodgkin
lymphoma
broad
spectrum
activ
display
vitro
vivo
leukemia
melanoma
breast
ovarian
colon
lung
nonsmal
cell
cancer
advanc
phase
clinic
trial
aplidin
affect
protein
synthesi
gtpdepend
inhibit
elong
factor
extract
palauan
ascidian
didemnum
guttatum
afford
sulfon
serinolipid
cyclodidemniserinol
trisulf
exhibit
antivir
effect
inhibit
integras
attract
target
antiretrovir
chemotherapi
macroalga
belong
three
main
phyla
rhodophyta
red
alga
chlorophyta
green
alga
phaeophyta
brown
alga
biolog
activ
identifi
extract
metabolit
algal
origin
includ
anticanc
antiobes
neuroprotect
antioxid
activ
scheme
show
chemic
structur
repres
bioactiv
compound
isol
macroalga
wide
rang
algal
speci
util
fresh
dri
form
food
particularli
asian
countri
folklor
tradit
govern
industri
medicin
usag
macroalga
sourc
agar
carrageenan
algin
import
food
industri
rang
compound
isol
algal
sourc
variabl
repres
exampl
bioactiv
constitu
macroalga
mention
cytotox
activ
identifi
diterpenoid
compound
dictyota
sp
collect
bangsaen
beach
thailand
antimalari
activ
also
found
diterpen
isol
extract
compound
test
malari
parasit
stypolacton
isol
brown
alga
stypopodium
zonal
found
exhibit
weak
cytotox
activ
vitro
evalu
cell
line
zonaquinon
acet
obtain
jamaican
popul
zonal
display
vitro
activ
breast
colon
cancer
cell
line
specimen
taonia
atomaria
produc
atomarianon
b
reportedli
found
cytotox
cell
line
fig
crude
extract
algal
speci
found
exhibit
rang
biolog
activ
exampl
aqueou
extract
gracilaria
corticata
sargassum
oligocystum
exhibit
bioactiv
cancer
human
leukemia
cell
methanol
extract
plocamium
telfairia
observ
display
bioactiv
colon
cancer
cell
antiinflammatori
activ
found
green
alga
dibromophenoxi
isol
activ
identifi
use
snake
toxininduc
mous
limb
model
also
exhibit
antiinflammatori
activ
mixtur
phytosterol
obtain
dunaliella
tertiolecta
administ
sheep
model
inflammationinduc
cytokin
product
inhibitori
effect
observ
polyphenol
extract
red
alga
laurencia
undulatea
display
antiinflammatori
activ
vivo
extract
serv
inhibit
asthmat
reaction
mice
sensit
challeng
ovalbumin
use
induc
murin
allerg
reaction
test
subject
antiinflamatori
agent
floridosid
disofloridosid
south
korean
alga
l
undulatea
found
inhibit
free
radic
oxid
stress
ic
valu
biolog
activ
compound
isol
brown
seawe
dictyota
cervicorni
obtain
sulfat
polysaccharid
power
anticoagul
activ
antioxid
activ
evalu
use
dpph
method
report
phenol
isol
halimeda
monil
liver
injuri
induc
rat
model
phenol
fraction
administ
period
led
protect
effect
chemic
harm
liver
ic
valu
potent
antimalari
activ
human
malari
parasit
p
falciparum
identifi
new
macrolid
bromophycolid
j
n
p
q
red
alga
callophycu
serratu
collect
fiji
marin
alga
halimeda
tuna
studi
koehn
cowork
lead
isol
halitun
diterpen
display
vitro
antivir
activ
murin
coronaviru
ecolog
import
role
play
compound
alga
sourc
exampl
halimedatri
diterpen
isol
halimeda
lamouroux
exhibit
toxic
toward
reef
fish
appear
feed
deterr
antimicrobi
activ
also
report
compound
almost
bioactiv
marin
compound
current
studi
obtain
marin
microorgan
microb
found
swab
surfac
marin
plant
anim
suspend
water
geotherm
vent
deep
water
environ
sediment
surfac
thrive
varieti
environ
includ
local
character
high
pressur
atmospher
high
temperatur
high
salin
effort
cultur
microorgan
met
vari
degre
success
abil
propag
microorgan
econom
feasibl
way
great
signific
potent
bioactiv
metabolit
discov
fig
marin
microorgan
found
surfac
marin
plant
anim
suspend
water
sediment
surfac
histor
terrestri
microb
potent
sourc
pharmaceut
agent
semin
discoveri
penicillin
discoveri
new
antibacteri
agent
seriou
prioriti
develop
potent
resist
current
antibiot
market
marin
bacteria
produc
wide
varieti
secondari
metabolit
purpos
defend
microb
scheme
show
structur
repres
compound
microorgan
associ
marin
specimen
marin
bacteria
produc
compound
biolog
signific
includ
pseudoalteromona
speci
found
produc
diphenyl
diol
inhibitor
methicillinresist
aureu
class
compound
tambjamin
isol
p
tunicata
found
activ
antifung
immunosuppress
antimicrobi
agent
biolog
activ
compound
marin
bacteria
also
includ
streptomyc
speci
sediment
fish
gut
anticanc
eg
halichomycin
antibacteri
agent
eg
phenazin
obtain
vibrio
speci
obtain
spong
specimen
produc
phenol
trisindol
compound
antibacteri
activ
micromonospora
sp
obtain
soft
coral
produc
thiocoralin
compound
exhibit
anticanc
activ
marin
fungi
also
known
produc
compound
rang
bioactiv
includ
antivir
antifung
enzym
inhibit
anticanc
antibacteri
activ
isol
cultiv
fungi
marin
environ
critic
import
propag
microb
biolog
relev
compound
may
obtain
protocol
establish
work
fungal
speci
produc
antibacteri
compound
includ
corallospora
pulchella
isol
sand
speci
produc
melinacidin
gencidin
anticanc
activ
report
metabolit
aspergillu
sp
includ
aspergillamid
fumiquinazolin
penicillium
sp
sourc
marin
alga
found
contain
pentostatin
communesin
among
compound
antivir
activ
attribut
presenc
halovir
identifi
scytalidium
sp
collect
seagrass
speci
potent
antivir
activ
h
simplex
viru
type
observ
may
act
bind
directli
viru
actinomycet
sourc
wide
rang
antimicrobi
agent
common
includ
tetracyclin
streptomycin
bioactiv
compound
origin
actinomycet
includ
antitumor
antimicrobi
agent
marinospora
sp
produc
group
bisindol
pyrrol
lynamicin
exhibit
biolog
activ
gramposit
gramneg
speci
importantli
activ
also
shown
drugresist
pathogen
includ
methicillinresist
aureu
anticanc
activ
lung
colon
breast
cancer
cell
line
exhibit
isol
ferment
streptomyc
sp
tartrolon
found
bioactiv
agent
microalga
found
seven
phyla
includ
chlorophyta
phaeophyta
rhodophyta
crystophyta
cryptophyta
eugelophyta
pyrrhophyta
bluegreen
alga
cyanophyta
cyanobacteria
found
share
characterist
eukaryot
alga
microalga
produc
compound
high
degre
structur
divers
speci
lyngbya
majuscula
produc
vast
array
biolog
activ
compound
curacin
eg
isol
gerwick
cowork
found
function
disturb
microtubul
assembl
therebi
function
lead
compound
chemotherapi
microcysti
aeruginosa
sourc
potent
protein
inhibitor
identifi
microcystin
microalg
speci
examin
includ
dinoflagel
produc
array
bioactiv
toxin
includ
saxitoxin
maitotoxin
function
block
activ
sodiumcalcium
channel
challeng
exist
respect
cultur
organ
due
rel
low
prolifer
rate
larg
quantiti
cultur
requir
obtain
small
amount
bioactiv
compound
diatom
microscop
unicellular
coloni
alga
grow
faster
rate
amen
cultur
bioactiv
metabolit
identifi
microalga
marin
compound
sourc
microb
clinic
signific
undergo
evalu
potenti
pharmaceut
agent
marinederiv
drug
pipelin
almost
nonexist
decad
gone
rang
candid
variou
stage
develop
shown
tabl
drug
phase
three
clinic
trial
includ
tetrodotoxin
guanidinium
alkaloid
trademark
name
tectin
obtain
pufferfish
affect
sodium
channel
drug
investig
treatment
chronic
pain
scheme
depsipeptid
tunic
plitidepsin
test
pharmamar
treatment
varieti
cancer
name
leukemia
multipl
myeloma
lymphoma
anoth
drug
evalu
pharmamar
cytotox
activ
zalypsi
sourc
mollusc
target
dnabind
capac
diseas
uterin
lymphoma
cervic
endometri
cancer
cell
alkaloidderiv
compound
anoth
drug
candid
pharmamar
evalu
efficaci
rang
cancer
includ
ovarian
breast
lung
acut
leukemia
endometri
cancer
bryostatin
bryozoan
bugula
neritina
involv
batteri
clinic
trial
investig
potenc
cancer
current
phase
evalu
treatment
alzheim
earli
year
challeng
associ
suppli
drug
underscor
fact
order
obtain
g
cgmp
qualiti
bryostatin
tonn
b
neritina
collect
californian
water
gene
cluster
uncultiv
microbi
symbiont
b
neritina
candidatu
endobugula
sertula
success
identifi
therebi
open
potenti
suppli
compound
kahalalid
f
cyclic
depsipeptid
found
mollusc
elysia
rufescen
well
green
alga
bryopsi
sp
feed
compound
current
phase
iii
trial
treatment
prostat
cancer
fig
dmxba
anabasein
deriv
anabesein
alkaloid
found
marin
worm
found
improv
cognit
anim
model
dmxba
relat
compound
demonstr
neuroprotect
activ
vitro
vivo
screen
thought
effect
macrophag
receptor
antiinflamatori
activ
also
observ
anim
model
phase
evalu
healthi
male
schizophren
shown
dmxba
led
mark
improv
cognit
function
sever
marin
compound
sourc
microb
clinic
signific
clinic
trial
conduct
plinabulin
vascular
disrupt
agent
obtain
marin
fungal
extract
potenti
activ
multidrug
resist
tumor
cell
marizomib
salinosporamid
isol
marin
bacterium
salinospora
tropica
novel
proteasom
inhibitor
current
investig
efficaci
solid
tumor
model
compound
exhibit
low
cytotox
normal
cell
signific
potenti
oral
intraven
administr
ultim
goal
mani
marin
natur
product
synthet
chemist
isol
synthes
molecul
possess
therapeut
applic
sever
food
drug
associ
fda
approv
drug
marin
origin
obtain
spong
fish
cone
snail
mollusc
cyanobacterium
speci
yond
trabectidin
obtain
ascidian
ecteinascidia
turbinata
approv
european
union
antitumor
effect
aqueou
ethanol
extract
e
turbinata
observ
vitro
trial
carri
human
cancer
cell
panel
compani
develop
drug
pharmamar
nation
cancer
institut
aquacultur
ascidian
prove
initi
strategi
use
obtain
suffici
quantiti
evalu
efficaci
compound
semisynthet
procedur
involv
ferment
pseudomona
florescen
current
employ
pharmaceut
prepar
drug
sold
countri
includ
south
korea
russia
trade
name
yond
yond
also
use
patient
relaps
platinumsensit
ovarian
cancer
drug
current
evalu
phase
ii
breast
prostat
lung
pediatr
cancer
spong
tethya
crypta
cryptotethia
crypta
origin
sourc
drug
cytarabin
develop
cytarabin
synthet
analogu
nucleosid
origin
isol
spong
sold
trade
name
cytosaru
cytotox
agent
inhibit
deoxyribonucl
acid
dna
polymeras
dna
synthesi
acut
lymphocyt
leukemia
nonhodgkin
lymphoma
acut
myelocyt
leukemia
among
condit
treat
drug
approv
fda
produc
ferment
streptomyc
griseu
cytarabin
limit
bioavail
improv
deliveri
system
made
slowreleas
liposom
form
cytarabin
depo
cyle
approv
unit
state
europ
prolong
administrationexposur
cerebrospin
fluid
relat
drug
vidarabin
viraa
develop
spongouridin
found
use
antivir
treatment
epitheli
superfici
kerat
caus
h
simplex
viru
type
viral
dna
polymeras
dna
synthesi
herp
inhibit
drug
discontinu
year
ago
drug
still
use
europ
ophthalmolog
challeng
prialt
ziconotid
obtain
peptid
mviia
isol
cone
snail
conu
magu
uniqu
mode
action
drug
act
revers
block
ntype
calcium
channel
specif
nerv
superfici
layer
spinal
cord
drug
use
manag
sever
chronic
pain
patient
suffer
cancer
acquir
immunodefici
syndrom
unabl
use
unrespons
drug
morphin
ziconotid
synthes
use
solidphas
peptid
synthesi
due
insuffici
quantiti
suppli
cone
snail
c
magu
blockag
spinal
cord
induc
drug
prevent
releas
neurotransmitt
respons
pain
specif
neuron
relat
conu
peptid
undergo
evalu
human
clinic
trial
brentuximab
vedotin
market
trade
name
adcetri
seattl
genet
gain
reput
treatment
hodgkin
system
anaplast
larg
cell
lymphoma
drug
analogu
dolastatin
compound
isol
sea
hare
dolobella
auricularia
later
found
produc
dietassoci
cyanobacteria
symploca
hydnoid
l
majuscula
preliminari
phase
ii
clinic
trial
dolastatin
relat
analogu
larg
unsuccess
antibodydrug
conjug
function
select
deliv
drug
cancer
cell
link
dolastatin
eg
antibodi
target
cell
membran
protein
surfac
hodgkin
lymphoma
cell
technolog
proven
semin
develop
fatti
acid
fish
oil
market
trade
name
lovaza
glaxosmithklin
use
treatment
hypotriglyceridemia
drug
control
ethyl
ester
eicosapentaeno
acid
docosahexaeno
acid
function
lower
triglycerid
level
eribulin
mesyl
e
trade
name
halaven
formul
macrolid
halichondrin
b
sourc
spong
h
okadai
studi
relat
anticanc
activ
simpler
analogu
halichondrin
b
show
effici
retain
lead
develop
eribulin
mesyl
water
solubl
parent
macrolid
approv
use
potent
irrevers
inhibit
cancer
cell
medic
drug
result
death
cell
apoptosi
absenc
tubulin
cell
growth
grind
halt
relat
compound
current
evalu
phase
ii
trial
one
recent
formul
market
carragelos
antivir
nasal
spray
function
creat
physic
antivir
barrier
nasal
caviti
compani
marinom
biotechnologi
gmbh
util
iotacarrageenan
sulfat
polysaccharid
found
rhodophycea
seawe
well
seawe
product
effect
earli
symptom
common
cold
note
addit
pharmaceut
applic
marinesourc
therapi
rang
cosmet
applic
also
exist
thrive
industri
foray
cosmet
applic
led
este
lauder
antiag
skin
care
remedi
resili
contain
extract
caribbean
sea
whip
pseudopterogorgia
elisabetha
activ
antiinflammatori
analges
agent
pseudopterosin
tricycl
diterpen
glycosid
found
inhibit
deriv
pseudopterosin
underw
phase
ii
trial
examin
wound
heal
effici
lipophil
insolubl
natur
compound
serv
limit
potenti
effect
drug
compound
group
tricycl
diterpen
glycosid
also
underw
preclin
evalu
antiinflammatori
drug
abyssin
market
product
use
sooth
reduc
irrit
skin
sensit
ultraviolet
b
light
well
chemic
mechan
attack
consist
extract
alteromona
speci
contain
high
molecular
weight
polym
two
differ
oligosaccharid
exopolysaccharid
seacod
repres
anoth
exopolysaccharid
occur
mixtur
extracellular
glycoprotein
glucid
exopolym
produc
ferment
pseudoalteromona
sp
product
found
improv
skin
rough
four
week
administr
refirmar
recent
product
introduc
obtain
intracellular
extract
ferment
new
pseudoalteromona
sp
isol
deep
hydrotherm
vent
portug
exclus
econom
zone
extract
cultur
biomass
afford
mixtur
macromolecul
inhibit
muscl
contract
hydrat
antiag
potenti
product
evalu
vivo
topic
appli
formul
area
marin
natur
product
chemistri
clearli
develop
leap
bound
evidenc
rel
larg
number
marinederiv
drug
undergo
evalu
potenti
therapeut
agent
buoy
potenti
develop
natur
product
sea
research
work
continu
advanc
discoveri
new
bioactiv
compound
new
applic
previous
isol
molecul
suppli
issu
howev
remain
one
critic
import
relat
develop
drug
marin
organ
exampl
spongistatin
report
highli
cytotox
deem
activ
natur
synthet
compound
investig
nation
institut
cancer
usa
three
tonn
spong
yield
mg
compound
anoth
collect
process
kg
spong
afford
mg
compound
isol
work
facilit
structur
elucid
work
ic
valu
compound
evalu
colon
cancer
cell
breast
cancer
cell
line
synthet
approach
compound
present
research
group
includ
petit
cowork
total
synthesi
biolog
activ
marin
compound
often
fraught
attend
challeng
due
length
multistep
synthet
procedur
gener
complex
structur
motif
must
take
account
stereochem
consider
propag
maricultur
aquacultur
also
studi
determin
viabil
use
approach
deal
challeng
associ
procur
suffici
quantiti
clinic
trial
subsequ
formul
drug
timelin
discov
drug
lead
entri
market
typic
span
period
time
capit
inject
consider
often
necessit
support
larg
pharmaceut
entiti
sometim
hesit
make
invest
may
yield
signific
financi
reward
caribbean
region
import
sourc
marin
speci
much
research
work
carri
like
becom
recipi
potenti
benefit
deriv
develop
unless
research
work
area
undertaken
region
support
appropri
collabor
futur
expect
new
strategi
employ
ensur
suppli
larg
quantiti
target
compound
includ
optim
ferment
techniqu
propag
microb
includ
mix
ferment
method
biotechnolog
approach
like
includ
whole
genom
sequenc
genom
mine
genet
engin
chemoenzymat
synthesi
vitro
enzymat
synthesi
hope
new
therapeut
drug
come
sea
requir
evalu
extract
potenti
drug
approach
would
adopt
silica
gel
chromatographi
essenti
purif
organ
compound
identifi
three
method
chromatographi
design
form
could
use
document
inform
collect
specimen
